Back to results
RecruitingPhase 3

A Phase 3 Study of Rotigotine in Combination with Rivastigmine in Mild to Moderate Alzheimer's Disease

NCT06702124

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Santa Lucia Foundation

Rome, Italy, Italy

Contact

Giacomo Koch, Prof

+390651501181g.koch@hsantlucia.it
View on ClinicalTrials.gov
A Phase 3 Study of Rotigotine in Combination with Rivastigmine in Mild to Moderate Alzheimer's Disease — TrialFind